Introduction
A common specific feature of tumor microenvironment is a hypoxia and an extracellular acidosis [1] . The aggressive and invasive cancer cells are well adapted to grow at low extracellular pH [1, 2] . The development of cancer is promoted by an acidic environment because acidic cancer cells have a biological advantage in these conditions as opposed to normal cells [1] [2] [3] . Thus, targeting of tumor acidity might be developed as an important predictive clinical marker of tumor aggressiveness and invasiveness and could be used in design of therapeutic agents. However, the bulk extracellular pH in tumors is just 0.5-0.8 pH units lower than the extracellular pH in healthy tissue [4] . But, the pH at cell surfaces is lower than the bulk extracellular pH [5] . A sharp proton concentration gradient exists near the surface of cancer cells, since protons are extensively pumped from the cytoplasm to the extracellular space, and membrane proteins, carbonic anhydrases, enhance extracellular acidity by hydrating cell-generated CO 2 into HCO 3 − and H + at cancer cell membranes [1] . As a result, an Bacidic crown^is formed around cancer cells. The pH increases with distance from the membrane and becomes normal in the vicinity of blood vessels [6] . Thus, the best approach is to target acidity in close proximity to cancer cells in tumors.
We have introduced family of pH low insertion peptides (pHLIP ® peptides), which represents a unique class of watersoluble membrane polypeptides capable to undergo a pHdependent membrane-associated folding [7, 8] . pHLIP ® peptides possess dual delivery capabilities, making use of the energy of folding to translocate polar cargo molecules across phospholipid bilayer of membrane and/or tether molecules to the surface of cancer cells [9] . The process of peptide folding within a membrane ensures a high cooperativity of the transition, which cannot be achieved by simple diffusion [10] [11] [12] . Since pHLIP ® peptides have affinity to cellular membranes at normal pH, they are capable of sensing pH at the cell surface. As soon as pH drops (even on a half of pH unit), the Asp and Glu residues are protonated enhancing affinity of the peptides to membrane, which triggers folding in membrane and formation of transmembrane helix accompanied with the release of energy [13, 14] . Depending on pHLIP ® sequence, protonatable residues could be differently located on membrane surface, which directly affects the rate of the protonation events at various pHs, and thus pK of peptide insertion into the membrane [10] [11] [12] . We have introduced family of pHLIP ® peptides with pK of insertion varying from 4.5 to 6.5 [10] . The targeting of primary tumors by pHLIP ® peptides and delivery imaging and therapeutic agents have been demonstrated on more than 10 varieties of human and murine tumors [15] [16] [17] , including lymphoma [18] , pancreatic [19] , breast [20, 21] , and prostate [22] transgenic mouse models and human head/neck biopsy samples [23, 24] . It was confirmed that tumor targeting by pHLIP ® peptides is indeed pH dependent and could be modulated by bicarbonate and glucose, which affects tumor acidity [15, 20, 21, 25, 26] . Three pHLIP ® variants, WT, Var3, and Va7, were selected as lead candidates for pH-specific delivery of imaging and therapeutic agents to tumors of different origins [10, 16, [19] [20] [21] .
This work is a continuation of our previous studies, which is designed for the comparison of tumor targeting and biodistribution of lead pHLIP ® sequences conjugated with cargoes, fluorescent dyes, of different polarity. 
Materials and Methods

Conjugation of pHLIP ® Peptides with Fluorescent Dyes
Absorbance and Fluorescence Measurements
Absorbance and fluorescence measurements were carried out on a Genesys 10S UV-Vis (Thermo Scientific) spectrophotometer and a SpectraMax M2 (Molecular Devices) spectrofluorometer, respectively. The excitation wavelengths were the following for different conjugates: 550 nm for AF546-pHLIPs, 650 nm for AF647-pHLIPs, and 673 nm for Cy5.5-pHLIPs; 680 nm for IR680-pHLIPs, Dy680-pHLIPs, and DyP680-pHLIPs; and 750 nm for AF750-pHLIPs and 780 nm for IR800-pHLIPs.
Cell Lines
The 4 T1 and 4 T1-GFP mouse mammary tumor cell lines were obtained from the American Type Culture Collection and cultured in RPMI medium supplemented with 10 % fetal bovine serum, 10 μg/ml of ciprofloxacin in a humidified atmosphere of 5 % CO 2 , and 95 % air at 37°C. All animal studies were conducted according to the animal protocol AN04-12-011 approved by the Institutional Animal Care and Use Committee at the University of Rhode Island, in compliance with the principles and procedures outlined by NIH for the Care and Use of Animals. 
Tumor Mouse Models
Fluorescent Imaging of Organs and Tissue
where F tumor , F muscle , and F backg are the mean fluorescence intensities of tumor, muscle, and background signal of the same organ from untreated mice, respectively. Fluorescent images of metastatic lesions in lungs were acquired at ×4 and ×10 magnification using an Olympus IX71 inverted fluorescence microscope.
Multivariate Statistical Analysis
Statistical agglomerative hierarchical clustering algorithm was applied to the database of 24 objects comprising 3 different pHLIP ® variants (WT, Var3, and Var7) conjugated with 8 fluorescent dyes, namely, AF546, AF647, AF750, Cy5.5, IR680, IR800, Dy680, and DyP680 spectral parameters, which were measured at time points of 2 and 4 h. The normalized fluorescent parameters measured in tumor (normalized fluorescence in tumor (NFT)), muscle (normalized fluorescence in muscle (NFM)), kidney (normalized fluorescence in kidney (NFK)), and liver (normalized fluorescence in liver (NFL)) and averaged over a number of mice tested per experiment were used in the analysis. The Euclidean metric was employed to compute distances, and Ward's minimum within-cluster variance criterion was applied as an amalgamation (linkage) rule. The results are presented in a form of hierarchical tree or dendrogram with height scaled to the percentage for convenience of interpretation. The calculations were performed using the hclust function in R.
Multivariate linear regression analysis was applied on a combined (not averaged) response of four fluorescent variables represented by NFT, NFM, NFL, and NFK and three categorical predictors represented by time (2, 4, and 24 h), dye (eight various fluorescent dyes), and pHLIP ® variants (Var3, Var7, and WT). The maximum-likelihood method was used to estimate a matrix of regression coefficients, which in the multivariate linear model is equivalent to equation-by-equation least squares estimation for the individual responses. Commonly employed multivariate analysis of variance (MANOVA) procedures such as Pillai-Bartlett trace, Hotelling-Lawley trace, and Wilks's lambda [27] were used to take into account correlation between four fluorescent variables and to check overall statistical significance of three categorical predictors. The calculations were performed using the lm and manova functions in R.
Results
We . S1 ). The selected fluorophores have similar molecular weights but different hydrophobicity reflected by differences in HPLC retention times shown in Table 1 .
With the selected fluorescent dye, AF750, we also investigated performance of the following pHLIP ® sequences, where the N-terminal end of the peptides contains six negatively charged Asp residues for the enhancement of peptide solubility:
In addition, we investigated biodistribution of the conjugates, where AF546 and Cy5.5 fluorescent dyes are attached to the single Cys residue at the membrane-inserting C-terminal e n d o f t h e V a r 3 p H L I P ® p e p t i d e ( V a r 3 -C : ADDQNPWRAYLDLLFPTDTLLLDLLCW) to access ability of Var3 to move cargo across lipid bilayer of membrane and compare fluorescent signals from the dye transferred to the cytoplasm and the dye, which stays in the extracellular space.
To test tumor targeting by the fluorescent pHLIP ® peptides, we selected the highly tumorigenic and invasive 4 T1 mammary carcinoma model, which mimics stage IV of human breast cancer [28] [29] [30] and is known to be acidic [31] and targeted very well by pHLIP ® peptides [20] . The fluorescent pHLIP ® peptides were administrated intravenously, and at different time points ranging from 2 to 48 h, animals were euthanized; tumor, kidney, liver, and muscle were collected and imaged immediately. The images were processed to calculate values of the mean surface fluorescence for each fluorescent pHLIP ® variant at each time point presented in Supplementary Table 1 together with the number of animals used in each case.
Different fluorescent pHLIP ® peptides demonstrate slightly different kinetic profiles (Fig. 1) ® variants. AF546 pHLIP ® peptides showed very low liver, kidney, and muscle accumulation with the highest tumor targeting. Tumor to muscle ratio for AF546-Var3 is found to be increasing from ∼5 to 9 within 24 h (see Fig. 3 and Supplementary Table S2 ). The pHLIP ® peptides conjugated with AF647, AF750, and IR800 dyes exhibit higher signal in kidney compared to AF546-labeled pHLIP ® variants. We also investigated performance of Dy680 and its pegylated version, DyP680. The DyP680 pHLIP ® variants are more polar compared to Dy680 pHLIP ® peptides. The most noticeable difference was observed in targeting of the kidney; DyP680 pHLIP ® peptides demonstrate about twice higher accumulation in the kidney compared to the Dy680 R.-C. Adochite et al.: Tumor Targeting by Fluorescent pHLIP ® Peptides 691 pHLIP ® peptides, which could be related to the renal clearance. Overall, the contrast index was enhanced for the pegylated versions of the conjugates compared to the nonpegylated counterparts.
The contrast index was calculated only for two time points, 2 and 4 h, since fluorescent signal in muscle at 24 and 48 h post-injection was at the level of the background fluorescence (Fig. 4 and Supplementary Table S3 ). We did not observe any significant difference in CI between various pHLIP ® sequences, except of AF546-Var3, which exhibits statistically significant higher CI compared to AF546-WT and AF546-Var7. The highest contrast (around 6) was observed for AF546, Dy680, and DyP680 at 2 h post-injection. At 4 h, the highest contrast of 98 was found for Cy5.5 pHLIP ® peptides. The lowest CI was detected for IR680 pHLIP ® peptides. We tested ability of pHLIP ® peptides to deliver imaging agents into cells. The inserting across membrane C-terminal part of Var3 of pHLIP ® peptide was conjugated with AF546 and Cy5.5. We selected the most hydrophobic dyes to avoid complications with their translocation across cellular membrane. Our data indicate that CI was very similar for the conjugates, where AF546 or Cy5.5 dyes are conjugated to the N-or C-terminus of the peptide. We can conclude that Var3 pHLIP ® peptide is capable of delivering cargo molecules, including imaging agents, not only to the cellular surface but also across membrane in cytoplasm. However, the polarity of cargo will affect the efficiency of its cellular delivery. Also, we evaluated performance of modified Var3M and Var7M pHLIP ® variants, where several Asp residues were added to the N-terminus of the peptides. The statistically significant improvement of CI was observed only for AF750-Var7M compared to AF750-Var7 (see Fig. 4 ).
To establish classification between the investigated fluorescently labeled pHLIP ® peptides, we applied statistical agglomerative hierarchical clustering (tree-clustering) algorithm to the 
692
R.-C. Adochite et al.: Tumor Targeting by Fluorescent pHLIP ® Peptides database of 24 objects comprising four normalized fluorescence parameters (NFT, NFM, NFL, and NFK) obtained on three different pHLIP ® variants conjugated with eight fluorescent dyes and measured at time points of 2 and 4 h. The main purpose was to build a tree-based hierarchical clustering solution, or dendrogram, to illustrate the similarities between the conjugates and the order at which they merge into clusters. The dendrograms for 2-and 4-h time points were constructed by joining of objects into clusters by using an Euclidian measure of distances between objects in the multidimensional space of analyzed fluorescent parameters and applying an amalgamation Ward's (linkage) rule [32] (see Fig. 5 ). The dendrogram height, which reflects the level of dissimilarity between clusters, was scaled to percentage for convenience of interpretation. The conjugates merged at the lower levels of height are more similar in terms of fluorescent parameters than those merged at the higher levels. Significant changes in the height of dendrogram may indicate the data partition into the appropriate number of clusters. We chose clustering algorithm because it does not require any a priori assumption about data distribution and allows us to reveal naturally existing classes and quantitatively estimate degrees of their distinctions, oppose to commonly used k-means or model-based clustering hierarchical approaches, which require a pre-defined number of classes. Our analysis allowed us to reveal three main clusters. The first cluster contains pHLIP ® variants conjugated with AF647, AF750, and IR800 fluorescent dyes. The second cluster is comprising of Cy5.5-labeled pHLIP ® peptides. And, third cluster contains all other fluorescent pHLIP ® peptides. We also performed multivariate linear regression analysis on a combined (not averaged) response of four fluorescent variables represented by NFT, NFM, NFL, and NFK and three categorical predictors represented by time (2, 4, and 24 h), dye (eight various fluorescent dyes), and pHLIP ® sequences (Var3, Var7, and WT). Unlike linear regression performed on each fluorescence parameter separately, multivariate regression takes into account natural correlation between all four parameters. Model coefficients for categorical predictors of time and pHLIP ® sequences are summarized in Table 2 . All coefficients marked by bold color indicate significant difference from the [33, 34] . The AF546-Var3 peptide was selected to study targeting of submillimeter metastatic lesions in lungs. 4 T1-GFP cancer cells were injected subcutaneously in the mammary fat pad of female mice. After approximately 3 weeks, the primary tumor was metastasized in the lungs. AF546-Var3 peptide was administrated as a single intravenous injection. At 4 h after injection of AF546-Var3, animals were euthanized and lungs were collected for ex vivo imaging. The freshly excised lungs were examined under fluorescent microscope. The cancerous lesions are identified by intracellular GFP fluorescence shown by green color in Fig. 6 . The AF546-Var3 fluorescence signal is observed from the extracellular space and cellular membranes (shown by red color in Fig. 6 ). The 400-600-μm-sized metastatic lesions were targeted by fluorescent pHLIP ® peptide very well.
Discussion
The peptides of pHLIP ® family are under development for delivery of imaging and therapeutic cargo molecules to cancer cells in tumors and other acidic diseased tissues. Since the most cargo molecules including NIR fluorescent dyes are large molecules (about 1 kDa in mass), they can affect and alter biodistribution of pHLIP ® peptides (about 4 kDa in mass). Here, we carried out a systematic investigation to compare targeting of 4 T1 mammary tumors, kidney, liver, and muscle at different time points after single intravenous administration of various pHLIP ® peptides conjugated with fluorescent dyes of different polarity.
Peptides conjugated with slightly hydrophobic molecules (such as AF546) demonstrate excellent targeting of tumors. It could be attributed to the stronger interactions of conjugates with plasma membranes of blood cells at neutral pH, which leads to the increase of circulation time in blood and ability to reach cancer cells followed by insertion and formation of stable transmembrane helical structures. The [10] .
Increase of cargo hydrophobicity (Cy5.5) leads to the increase of conjugate accumulation in liver, which is indicative of switch from renal to hepatic clearance. Also, tumor targeting and tumor accumulation are significant and increase with time, while conjugates are washed from major organs.
The pHLIP ® peptides conjugated with polar NIR dyes, such as AF750 and IR800, showed very similar tumor targeting and biodistribution. The accumulation in kidney was the highest for these conjugates. Interestingly, pHLIP ® peptides conjugated with a more polar DyP680 (pegylated version of the Dy680) also exhibit higher accumulation in kidney compared to less polar Dy680 pHLIP ® conjugates. In addition to targeting of primary breast tumors, we demonstrated targeting of submillimeter metastatic lesions in lungs by AF546-Var3. Apparently, these small lesions were acidic, since they were stained well by fluorescent pHLIP ® . Use of pHLIP ® peptides opens an opportunity of investigating, imaging, and treating of metastatic lesions.
The fluorescent pHLIP ® peptides also could have an important implication for staining and visualization of cancerous lesions during surgical procedures [35] . Fluorescence-guided surgery has the promise to improve surgical procedures by determining tumor margins and staining flat lesions using tumor-specific targeting and by increasing the visual information available to the surgeon [36] . There is a variety of tumor-specific agents that are under development for imaging of tumors [37] . Fluorescent pHLIP ® could be a novel universal agent, since it can target various tumors with high accuracy.
In summary, we can conclude that pHLIP ® peptides show excellent targeting of primary tumors and metastatic lesions. By tuning of peptide sequence or link between peptides and cargo, the biodistribution could be altered. This is especially important for the selective tumor delivery of therapeutic cargo molecules.
